pyrazines has been researched along with Castleman Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, X; Fang, B; Huang, H; Li, Y; Lin, Q; Song, Y; Xia, Q; Yu, F; Zhang, Y; Zhou, J | 1 |
| Dun, XY; Hou, J; Li, YH; Yuan, ZG | 1 |
| Alonso Vence, N; Bello Lopez, JL; Bendaña Lopez, A; Diaz Arias, J; Fraga Rodriguez, M; Sobas, MA | 1 |
| Gao, J; Wang, X; Xiao, C; Xing, X; Xiong, C; Ye, S | 1 |
| Besa, E; Bray, P; Caro, J; Dulau Florea, A; Mahipal, A; Sbenghe, MM | 1 |
| Aggarwal, S; Bhargava, M; Khan, AA; Siraj, F | 1 |
| Li, J; Zhou, DB | 1 |
| Hess, G; Heussel, CP; Huber, C; Kreft, A; Wagner, V | 1 |
1 review(s) available for pyrazines and Castleman Disease
| Article | Year |
|---|---|
New advances in the diagnosis and treatment of POEMS syndrome.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Castleman Disease; Chromosome Aberrations; Combined Modality Therapy; Dexamethasone; Disease Management; Drug Therapy, Combination; Genes, Immunoglobulin; Humans; Hypertension, Pulmonary; Lenalidomide; Melphalan; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; Plasma Cells; POEMS Syndrome; Prognosis; Pyrazines; Severity of Illness Index; Symptom Assessment; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2013 |
7 other study(ies) available for pyrazines and Castleman Disease
| Article | Year |
|---|---|
Efficacy of bortezomib and thalidomide in the recrudescent form of multicentric mixed-type Castleman's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Castleman Disease; Humans; Male; Pyrazines; Thalidomide | 2015 |
Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case report.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Castleman Disease; Humans; Male; Multiple Myeloma; Neoplasms, Multiple Primary; Pyrazines; Remission Induction | 2009 |
Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
Topics: Boronic Acids; Bortezomib; Castleman Disease; Humans; Male; Middle Aged; POEMS Syndrome; Protease Inhibitors; Pyrazines; Treatment Outcome | 2010 |
Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
Topics: Adult; Angiogenesis Inhibitors; Boronic Acids; Bortezomib; Castleman Disease; Drug Therapy, Combination; Humans; Male; POEMS Syndrome; Pyrazines; Thalidomide; Vascular Endothelial Growth Factor A | 2011 |
HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.
Topics: Adult; Boronic Acids; Bortezomib; Castleman Disease; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV; Humans; Male; Pyrazines; Rare Diseases | 2012 |
Successful treatment of multicentric Castleman's disease accompanying myeloma with bortezomib.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Castleman Disease; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Remission Induction | 2012 |
Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease.
Topics: Blood Transfusion; Boronic Acids; Bortezomib; Castleman Disease; Female; Humans; Interleukin-6; Middle Aged; Protease Inhibitors; Pyrazines; Treatment Outcome | 2006 |